14.1% Global CAGR for Brain Aneurysm Treatment Market Market to achieve US$ 6,222.47 Mn by 2027

Stryker and Medtronic – Significant Players in brain aneurysm treatment Market

Brain aneurysm is a development of bulge in the blood vessels of brain. This bulging puts pressure on the nerves or brain tissues. This bulge may rupture or burse and can cause brain hemorrhage, which may lead to the death of patient. Certain factors such as genetic conditions, arteriovenous malformations, untreated high blood pressure, and smoking are responsible to cause brain aneurysm.

Market leaders operating in the market have undertaken various organic growth strategies in the brain aneurysm treatment market. The brain aneurysm treatmentmarket majorly consists of the players such Stryker Corporation, MicroPort Scientific Corporation, Terumo Corporation, Mizuho Medical Co, Ltd, Penumbra, Inc., Medtronic, Johnson & Johnson Services, Inc., KANEKA CORPORATION, adeor medical AG, and Evasc Medical Systems Corp among others. Several organic approaches, such as product launches, and expansion/relocation in the brain aneurysm treatment market, have resulted in the positive growth of the market. Product launches help the company to strengthen its product offering and the customer base, which allows the company to hold a strong position in the market. Similarly, utilizing expansion activities, it is easy to venture into untapped economies and use the opportunities being offered.

Below is the list of the growth strategies done by the players operating in the brain aneurysm treatment market: